4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-062827
Chief Financial Officer sold 445 shares at $14.49 ($6,448)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2022-12-27 | Sale | −445 | $14.49 | $6,448 | 50,231 | D |
| Open-market sales · 445 sh · avg $14.49 · $6,448 | |||||||
Loading xslF345X03/doc4.xml…